# A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

> **NCT06953739** · PHASE3 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- NK-T-Cell Lymphoma, Extranodal

## Interventions

- **DRUG:** P-GEMD
- **DRUG:** P-Gemox

## Key facts

- **NCT ID:** NCT06953739
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953739, "A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT06953739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*